Marquart Hanne Vibeke, Schejbel Lone, Sjoholm Anders, Martensson Ulla, Nielsen Susan, Koch Anders, Svejgaard Arne, Garred Peter
Dept. of Clinical Immunology sect. 7631, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, Denmark.
Clin Immunol. 2007 Jul;124(1):33-40. doi: 10.1016/j.clim.2007.03.547. Epub 2007 May 21.
C1q deficiency is a rare condition associated with a systemic lupus erythematosus (SLE)-like syndrome and recurrent infections. Here we present the molecular basis behind C1q deficiency in three sisters of Inuit origin. Initial examination for complement deficiency showed no function of the classical complement activation pathway in the patients; the lectin and alternative pathways were intact. No C1q or low molecular weight C1q was detected in sera and no anti-C1q autoantibodies were found. Sequencing of the C1q genes revealed a novel missense mutation (Gly-Arg) in codon 217 of the B chain. All sisters were homozygous for the mutation: both parents were heterozygous. None of 100 healthy controls carried the mutation. Our findings define a third class of molecular mechanisms behind C1q deficiency, where missense mutations cause a lack of detectable C1q-antigen in serum.
C1q缺陷是一种罕见病症,与系统性红斑狼疮(SLE)样综合征及反复感染相关。在此,我们阐述了三名因纽特族姐妹C1q缺陷背后的分子基础。补体缺陷的初步检查显示,患者体内经典补体激活途径无功能;凝集素和替代途径完好无损。血清中未检测到C1q或低分子量C1q,也未发现抗C1q自身抗体。C1q基因测序显示,B链第217密码子存在一个新的错义突变(甘氨酸-精氨酸)。所有姐妹均为该突变的纯合子:父母均为杂合子。100名健康对照者均未携带该突变。我们的研究结果确定了C1q缺陷背后的第三类分子机制,即错义突变导致血清中缺乏可检测到的C1q抗原。